Wee eugene j h (31 résultats)
- Couverture rigide
Vendeur : Romtrade Corp., STERLING HEIGHTS, MI, Etats-UnisRomtrade Corp.
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 109,36
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : 1 disponible(s)
Etat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
- Couverture rigide
Vendeur : Basi6 International, Irving, TX, Etats-UnisBasi6 International
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 109,36
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : 1 disponible(s)
Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Langue : anglais
Edité par VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
- Couverture souple
Vendeur : Books Puddle, New York, NY, Etats-UnisBooks Puddle
Contacter le vendeurVendeur avec une évaluation de 4 étoilesEtat: Neuf
EUR 111,66
EUR 3,47 expéditionExpédition nationale : Etats-UnisQuantité disponible : 4 disponible(s)
Etat : New. pp. 188.
- Couverture rigide
Vendeur : Basi6 International, Irving, TX, Etats-UnisBasi6 International
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 119,50
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : 1 disponible(s)
Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
- Autres images
- Couverture souple
Vendeur : preigu, Osnabrück, Allemagnepreigu
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 61,05
EUR 70,00 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 5 disponible(s)
Taschenbuch. Etat : Neu. Promoter DNA Methylation of miRNAs as Breast Cancer Biomarkers | From biomarker discovery to biotechnology development | Eugene J. H. Wee | Taschenbuch | 188 S. | Englisch | 2013 | LAP LAMBERT Academic Publishing | EAN 9783659505072 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher L…andstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
- Couverture rigide
Vendeur : Books Puddle, New York, NY, Etats-UnisBooks Puddle
Contacter le vendeurVendeur avec une évaluation de 4 étoilesEtat: Occasion
EUR 141,47
EUR 3,47 expéditionExpédition nationale : Etats-UnisQuantité disponible : 1 disponible(s)
Etat : Used. pp. 210 Index.
- Couverture rigide
Vendeur : Majestic Books, Hounslow, Royaume-UniMajestic Books
Contacter le vendeurVendeur avec une évaluation de 4 étoilesEtat: Occasion
EUR 145,41
EUR 7,58 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 1 disponible(s)
Etat : Used. pp. 210.
- Autres images
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Couverture rigide
Vendeur : GreatBookPrices, Columbia, MD, Etats-UnisGreatBookPrices
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 160,80
EUR 2,29 expéditionExpédition nationale : Etats-UnisQuantité disponible : 3 disponible(s)
Etat : New.
- Couverture rigide
Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 163,17
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : 3 disponible(s)
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Wee Eugene J.H. Shiddiky Muhammad J.A. Trau Matt Rauf Sakandar
- Couverture rigide
Vendeur : Biblios, frankfurt am main, HESSE, AllemagneBiblios
Contacter le vendeurVendeur avec une évaluation de 4 étoilesEtat: Occasion
EUR 148,03
EUR 9,95 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 1 disponible(s)
Etat : Used. pp. 210.
- Autres images
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Couverture rigide
Vendeur : GreatBookPrices, Columbia, MD, Etats-UnisGreatBookPrices
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Occasion - Comme neuf
EUR 171,92
EUR 2,29 expéditionExpédition nationale : Etats-UnisQuantité disponible : 3 disponible(s)
Etat : As New. Unread book in perfect condition.
- Couverture rigide
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 174,35
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : 1 disponible(s)
Hardcover. Etat : new. Hardcover. In recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored specifically for individuals, is becoming a reality. Significant advan…ces in biomarker-based research methodologies such as Next Generation Sequencing (NGS) are at the cusp of ushering in a new era of personal medicine. However, unlike the spectacular advances in research technologies for disease biomarker discovery, biomarker-based technologies that can effectively be used in the clinic (or point-of-care) to enable personalised medicine are still lacking. In this book, we feature a selection of emerging technologies which are aimed at enabling clinical applications of personalised medicine. Each of the eight chapters is written by a leading group at the intersection of microfluidics, biology, and nanotechnology.For instance, to accelerate a major bottleneck in the development of clinically useful protein diagnostics, we discuss the application of yeast-derived single chain Fragment variable (scFv) antibody-like molecules as a potential low cost alternative to traditional antibody-based diagnostics. Circulating tumour cells (CTCs) are an emerging class of cancer biomarkers and a potential resource for understanding cancer progression; we explore various strategies combining microfluidics with nanotechnology for capturing CTCs. The book includes an evaluation of some current and emerging technologies for detecting clinical DNA methylation, another potential cancer biomarker. As personalised medicine may involve tracking a patient's response to treatment, the application of microfluidics to detect metabolites in biological fluids is also discussed. Finally, the ultimate goal of personalised medicine is targeted therapy. One promising approach is RNAi technology which uses short nucleotides to disrupt cancer pathways. In this book, nanoparticle approaches to deliver these short nucleotides are discussed. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
- Couverture rigide
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 169,45
EUR 5,86 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 3 disponible(s)
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.
- Autres images
- Couverture rigide
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-UniRarewaves.com USA
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 178,32
Frais de port gratuitsExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 2 disponible(s)
Hardback. Etat : New.
- Couverture rigide
- Édition originale
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandeKennys Bookshop and Art Galleries Ltd.
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 170,79
EUR 9,50 expéditionExpédition depuis Irlande vers Etats-UnisQuantité disponible : 2 disponible(s)
Etat : New. Editor(s): Shiddiky, Muhammad J. A.; Wee, Eugene J. H.; Rauf, Sakandar; Trau, Matt. Num Pages: 227 pages. BIC Classification: MBGR. Category: (P) Professional & Vocational. Dimension: 258 x 183 x 18. Weight in Grams: 556. . 2013. 1st Edition. Hardcover. . . . .
- Autres images
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Couverture rigide
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-UniGreatBookPricesUK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 167,62
EUR 17,50 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 3 disponible(s)
Etat : New.
- Autres images
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Couverture rigide
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-UniGreatBookPricesUK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Occasion - Comme neuf
EUR 172,22
EUR 17,50 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 3 disponible(s)
Etat : As New. Unread book in perfect condition.
- Couverture rigide
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-UniTHE SAINT BOOKSTORE
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 178,80
EUR 19,78 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 3 disponible(s)
Hardback. Etat : New. New copy - Usually dispatched within 4 working days.
- Autres images
- Couverture rigide
Vendeur : moluna, Greven, Allemagnemoluna
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 170,27
EUR 48,99 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 3 disponible(s)
Etat : New. KlappentextrnrnIn recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored spec.
- Couverture rigide
Vendeur : Kennys Bookstore, Olney, MD, Etats-UnisKennys Bookstore
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 215,36
EUR 9,12 expéditionExpédition nationale : Etats-UnisQuantité disponible : 2 disponible(s)
Etat : New. Editor(s): Shiddiky, Muhammad J. A.; Wee, Eugene J. H.; Rauf, Sakandar; Trau, Matt. Num Pages: 227 pages. BIC Classification: MBGR. Category: (P) Professional & Vocational. Dimension: 258 x 183 x 18. Weight in Grams: 556. . 2013. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
- Couverture rigide
Vendeur : Gazelle Books, Lancaster, LANCA, Royaume-UniGazelle Books
Contacter le vendeurVendeur avec une évaluation de 4 étoilesEtat: Neuf
EUR 175,77
EUR 64,18 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 3 disponible(s)
Hardback. Etat : New. New Book, Direct from Publisher.
- Autres images
- Couverture rigide
Vendeur : Rarewaves.com UK, London, Royaume-UniRarewaves.com UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 167,67
EUR 75,85 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 2 disponible(s)
Hardback. Etat : New.
- Autres images
- Couverture rigide
Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 210,10
EUR 62,77 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 2 disponible(s)
Buch. Etat : Neu. Neuware - In recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored specifically for individuals, is becoming a reality. Significant advances in… biomarker-based research methodologies such as Next Generation Sequencing (NGS) are at the cusp of ushering in a new era of personal medicine. However, unlike the spectacular advances in research technologies for disease biomarker discovery, biomarker-based technologies that can effectively be used in the clinic (or point-of-care) to enable personalised medicine are still lacking. In this book, we feature a selection of emerging technologies which are aimed at enabling clinical applications of personalised medicine. Each of the eight chapters is written by a leading group at the intersection of microfluidics, biology, and nanotechnology. For instance, to accelerate a major bottleneck in the development of clinically useful protein diagnostics, we discuss the application of yeast-derived single chain Fragment variable (scFv) antibody-like molecules as a potential low cost alternative to traditional antibody-based diagnostics. Circulating tumour cells (CTCs) are an emerging class of cancer biomarkers and a potential resource for understanding cancer progression; we explore various strategies combining microfluidics with nanotechnology for capturing CTCs. The book includes an evaluation of some current and emerging technologies for detecting clinical DNA methylation, another potential cancer biomarker. As personalised medicine may involve tracking a patient's response to treatment, the application of microfluidics to detect metabolites in biological fluids is also discussed. Finally, the ultimate goal of personalised medicine is targeted therapy. One promising approach is RNAi technology which uses short nucleotides to disrupt cancer pathways. In this book, nanoparticle approaches to deliver these short nucleotides are discussed.
- Couverture rigide
Vendeur : AussieBookSeller, Truganina, VIC, AustralieAussieBookSeller
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 255,12
EUR 32,15 expéditionExpédition depuis Australie vers Etats-UnisQuantité disponible : 1 disponible(s)
Hardcover. Etat : new. Hardcover. In recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored specifically for individuals, is becoming a reality. Significant advan…ces in biomarker-based research methodologies such as Next Generation Sequencing (NGS) are at the cusp of ushering in a new era of personal medicine. However, unlike the spectacular advances in research technologies for disease biomarker discovery, biomarker-based technologies that can effectively be used in the clinic (or point-of-care) to enable personalised medicine are still lacking. In this book, we feature a selection of emerging technologies which are aimed at enabling clinical applications of personalised medicine. Each of the eight chapters is written by a leading group at the intersection of microfluidics, biology, and nanotechnology.For instance, to accelerate a major bottleneck in the development of clinically useful protein diagnostics, we discuss the application of yeast-derived single chain Fragment variable (scFv) antibody-like molecules as a potential low cost alternative to traditional antibody-based diagnostics. Circulating tumour cells (CTCs) are an emerging class of cancer biomarkers and a potential resource for understanding cancer progression; we explore various strategies combining microfluidics with nanotechnology for capturing CTCs. The book includes an evaluation of some current and emerging technologies for detecting clinical DNA methylation, another potential cancer biomarker. As personalised medicine may involve tracking a patient's response to treatment, the application of microfluidics to detect metabolites in biological fluids is also discussed. Finally, the ultimate goal of personalised medicine is targeted therapy. One promising approach is RNAi technology which uses short nucleotides to disrupt cancer pathways. In this book, nanoparticle approaches to deliver these short nucleotides are discussed. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
- Couverture rigide
Vendeur : BOOKIT!, Genève, SuisseBOOKIT!
Contacter le vendeurVendeur avec une évaluation de 3 étoilesEtat: Occasion - Comme neuf
EUR 608,10
EUR 53,50 expéditionExpédition depuis Suisse vers Etats-UnisQuantité disponible : 1 disponible(s)
Etat : Used: Like New. LIVRE A L?ETAT DE NEUF. EXPEDIE SOUS 3 JOURS OUVRES. NUMERO DE SUIVI COMMUNIQUE AVANT ENVOI, EMBALLAGE RENFORCE. EAN:9781628080209.
- Autres images
- Couverture souple
- impression à la demande
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AllemagneBuchWeltWeit Ludwig Meier e.K.
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 71,90
EUR 23,00 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 2 disponible(s)
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Breast cancer is a complex disease with many factors that can contribute to its development. As such, informative biomarkers are required to accurately and comprehensively characterize breast cancer so that patient management is both in…formed and optimal. Current breast cancer biomarkers, although useful, have limitations and are sometimes unable to classify all breast cancer patients. Therefore, new classes of biomarkers and detection tools are needed. A possible complement to existing biomarkers is the aberrant DNA methylation of miRNA promoters in breast cancer. This book will take the reader on a journey from discovering a novel biomarker to developing a new technology for detecting this potential biomarker in clinical practice. The genetics/biotechnology interdisciplinary combination may appeal to readers majoring in either field and to anyone interested in interdisciplinary research. 188 pp. Englisch.
- Autres images
- Couverture souple
- impression à la demande
Vendeur : moluna, Greven, Allemagnemoluna
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 58,12
EUR 48,99 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : Plus de 20 disponibles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Wee Eugene J.H.Eugene J.H. Wee, PhD in cancer genetics from The University of Queensland, Australia. Postdoctoral researcher at the Australian Institute for Bioengineering and Nanotechnology.Breast cancer i…s a complex disease wit.
Langue : anglais
Edité par VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
- Couverture souple
- impression à la demande
Vendeur : Majestic Books, Hounslow, Royaume-UniMajestic Books
Contacter le vendeurVendeur avec une évaluation de 4 étoilesEtat: Neuf
EUR 114,06
EUR 7,58 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 4 disponible(s)
Etat : New. Print on Demand pp. 188 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
Langue : anglais
Edité par VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
- Couverture souple
- impression à la demande
Vendeur : Biblios, frankfurt am main, HESSE, AllemagneBiblios
Contacter le vendeurVendeur avec une évaluation de 4 étoilesEtat: Neuf
EUR 116,42
EUR 9,95 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 4 disponible(s)
Etat : New. PRINT ON DEMAND pp. 188.
- Autres images
- Couverture souple
- impression à la demande
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagnebuchversandmimpf2000
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 71,90
EUR 60,00 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 1 disponible(s)
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Breast cancer is a complex disease with many factors that can contribute to its development. As such, informative biomarkers are required to accurately and comprehensively characterize breast cancer so that patient management is both inform…ed and optimal. Current breast cancer biomarkers, although useful, have limitations and are sometimes unable to classify all breast cancer patients. Therefore, new classes of biomarkers and detection tools are needed. A possible complement to existing biomarkers is the aberrant DNA methylation of miRNA promoters in breast cancer. This book will take the reader on a journey from discovering a novel biomarker to developing a new technology for detecting this potential biomarker in clinical practice. The genetics/biotechnology interdisciplinary combination may appeal to readers majoring in either field and to anyone interested in interdisciplinary research.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 188 pp. Englisch.
